Altered expression of serum protein in ginsenoside Re-treated diabetic rats detected by SELDI-TOF MS

Journal of Ethnopharmacology

Volumn 108, Issue 2, 2006, Pages 272-279

  Cho, William C S ^a   Yip, Tai Tung ^b   Chung, Wai Shing ^a   Lee, Sally K W ^a   Leung, Albert W N ^c   Cheng, Christopher H K ^d   Yue, Kevin K M ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b CIPHERGEN BIOSYSTEMS INC   (United States)

^c Hong Kong   (Hong Kong)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

C reactive protein; Diabetes mellitus; Ginsenoside Re; Panax ginseng; SELDI TOF MS; Traditional Chinese medicine

Indexed keywords

ADMINISTRATION, ORAL; ANIMALS; BLOOD PROTEINS; C-REACTIVE PROTEIN; DIABETES MELLITUS, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GINSENOSIDES; MALE; MEDICINE, CHINESE TRADITIONAL; PROTEOME; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STREPTOZOCIN; TIME FACTORS;

PANAX GINSENG; RATTUS;

EID: 33749997319     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.05.009     Document Type: Article

References (32)

1. Arulmozhi D.K., Veeranjaneyulu A., and Bodhankar S.L. Neonatal streptozotocin-induced rat model of type 2 diabetes mellitus: a glance. Indian Journal of Pharmacology 36 (2004) 217-221
2. Attele A.S., Zhou Y.P., Xie J.T., Wu J.A., Zhang L., Dey L., Pugh W., Rue P.A., Polonsky K.S., and Yuan C.S. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 5 (2002) 1851-1858
3. Cabral de Oliveira A.C., Perez A.C., Merino G., Prieto J.G., and Alvarez A.I. Protective effects of Panax ginseng on muscle injury and inflammation after eccentric exercise. Comparative Biochemistry and Physiology, Toxicology and Pharmacology 130 (2001) 369-377
4. Cho W.C., Yip T.T., Yip C., Yip V., Thulasiraman V., Ngan R.K., Yip T.T., Lau W.H., Au J.S., Law S.C., Cheng W.W., Ma V.W., and Lim C.K. Identification of serum amyloid A protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clinical Cancer Research 10 (2004) 43-52
5. Cho W.C., Yue K.K., and Leung A.W. An outline of diabetes mellitus and its treatments by traditional Chinese medicine and acupuncture. Journal of Chinese Medicine (UK) 78 (2005) 29-37
6. Cho W.C., Yue K.K., and Leung A.W. Proteomics-leading the postgenome era. China Biotechnology 25 (2005) 33-38
7. Cho W.C., Yip T.T., Chung W.S., Leung A.W., Cheng C.H., and Yue K.K. Differential expression of proteins in kidney, eye, aorta, and serum of diabetic and non-diabetic rats. Journal of Cellular Biochemistry (2006) (epub ahead of print)
8. Cho W.C., Yip T.T., Chung W.S., Leung A.W., Cheng C.H., and Yue K.K. Potential biomarkers found by protein profiling may provide insight for the macrovascular pathogenesis of diabetes mellitus. Disease Markers 22 (2006) 153-166
9. Colhoun H.M., Schalkwijk C., Rubens M.B., and Stehouwer C.D. C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification. Diabetes Care 25 (2002) 1813-1817
10. Elenkov I.J., Iezzoni D.G., Daly A., Harris A.G., and Chrousos G.P. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12 (2005) 255-269
11. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102 (2000) 42-47
12. Folsom A.R., Aleksic N., Catellier D., Juneja H.S., and Wu K.K. C-reactive protein and incident coronary heart disease in the atherosclerosis risk in communities (ARIC) study. American Heart Journal 144 (2002) 233-238
13. Fung E.T., and Enderwick C. ProteinChip clinical proteomics: computational challenges and solutions. BioTechniques Supplement 3 (2002) 34-38,40-41
14. Gribonval R. From projection pursuit and CART to adaptive discriminator analysis?. IEEE Transactions on Neural Networks 16 (2005) 522-532
15. Ilhan F., Akbulut H., Karaca I., Godekmerdan A., Ilkay E., and Bulut V. Procalcitonin, C-reactive protein and neopterin levels in patients with coronary atherosclerosis. Acta Cardiologica 60 (2005) 361-365
16. Jayakar S.D. A principal component analysis of quantitative serum protein data. La Ricerca in Clinica e in Laboratorio 10 (1980) 243-246
17. Koenig W., Sund M., Frohlich M., Fischer H.G., Lowel H., Doring A., Hutchinson W.L., and Pepys M.B. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
18. Lee T.K., Johnke R.M., Allison R.R., O'Brien K.F., and Dobbs Jr. L.J. Radioprotective potential of ginseng. Mutagenesis 20 (2005) 237-243
19. Liu C.X., and Xiao P.G. Recent advances on ginseng research in China. Journal of Ethnopharmacology 36 (1992) 27-38
20. Mayr M., Mayr U., Chung Y.L., Yin X., Griffiths J.R., and Xu Q. Vascular proteomics: linking proteomic and metabolomic changes. Proteomics 4 (2004) 3751-3761
21. Nettleman M.D. Receiver operator characteristic (ROC) curves. Infection Control and Hospital Epidemiology 9 (1988) 374-377
22. Reid M.S., and Blobel C.P. Apexin, an acrosomal pentaxin. The Journal of Biological Chemistry 269 (1994) 32615-32620
23. Ridker P.M., and Haughie P. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. Journal of Investigative Medicine 46 (1998) 391-395
24. Romero I.R., Morris C., Rodriguez M., Du Clos T.W., and Mold C. Inflammatory potential of C-reactive protein complexes compared to immune complexes. Clinical Immunology and Immunopathology 87 (1998) 155-162
25. Schalkwijk C.G., Poland D.C., van Dijk W., Kok A., Emeis J.J., Drager A.M., Doni A., van Hinsbergh V.W., and Stehouwer C.D. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 42 (1999) 351-357
26. Xie J.T., Mehendale S.R., Li X., Quigg R., Wang X., Wang C.Z., Wu J.A., Aung H.H., Rue P.A., Bell G.I., and Yuan C.S. Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochimica et Biophysica Acta 1740 (2005) 319-325
27. Xie J.T., Mehendale S.R., and Yuan C.S. Ginseng and diabetes. The American Journal of Chinese Medicine 33 (2005) 397-404
28. Yip T.T., Chan J.W., Cho W.C., Yip T.T., Wang Z., Kwan T.L., Law S.C., Tsang D.N., Chan J.K., Lee K.C., Cheng W.W., Ma V.W., Yip C., Lim C.K., Ngan R.K., Au J.S., Chan A., and Lim W.W. Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid A protein as a biomarker potentially useful in monitoring the extent of pneumonia. Clinical Chemistry 51 (2005) 47-55
29. Yue K.K., Chung W.S., Leung A.W., and Cheng C.H. Redox changes precede the occurrence of oxidative stress in eyes and aorta, but not in kidneys of diabetic rats. Life Sciences 73 (2003) 2557-2570
30. Yue K.K., Leung S.N., Man P.M., Yeung W.F., Chung W.S., Lee K.W., Leung A.W., and Cheng C.H. Alterations in antioxidant enzyme activities in the eyes, aorta and kidneys of diabetic rats relevant to the onset of oxidative stress. Life Sciences 77 (2005) 721-734
31. Yun T.K. Brief introduction of Panax ginseng C.A. Meyer. Journal of Korean Medical Science 16 (2001) S3-S5
32. Zhou W., Chai H., Lin P.H., Lumsden A.B., Yao Q., and Chen C.J. Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease. Medical Science Monitor 10 (2004) 187-192